RESUMEN
ABSTRACT Introduction: preeclampsia can be associated with future renal disease. Objectives: To measure changes in renal function overtime in patients with preeclampsia. Methods: urine and serum samples from eleven patients with preeclampsia and eight patients with a normal pregnancy were obtained during pregnancy, postpartum, and 3 years after delivery. Urine podocalyxin, protein, and serum creatinine were measured. Results: after 3 years, there were no significant differences in urinary podocalyxin in patients with or without preeclampsia: 4.34 ng/mg [2.69, 8.99] vs. 7.66 ng/mg [2.35, 13], p = 0.77. The same applied to urinary protein excretion: 81.5 mg/g [60.6, 105.5] vs. 43.2 mg/g [20.9, 139.3] p = 0.23. Serum creatinine was 0.86 mg/dL [0.7, 0.9] vs. 0.8 mg/dL [0.68, 1] p = 0.74 in those with and without preeclampsia. In normal patients, urinary podocalyxin decreased from 54.4 ng/mg [34.2, 76.9] during pregnancy to 7.66 ng/mg [2.35, 13] three years after pregnancy, p = 0.01. Proteinuria decreased from 123.5 mg/g [65.9, 194.8] to 43.2 mg/g [20.9, 139.3], p = 0.12. In preeclampsia patients, urinary podocalyxin decreased from 97.5 ng/mg [64.9, 318.4] during pregnancy to 37.1 ng/mg within one week post-partum [21.3, 100.4] p = 0.05 and 4.34 ng/mg [2.69, 8.99] three years after, p = 0.003. Proteinuria was 757.2 mg/g [268.4, 5031.7] during pregnancy vs. 757.2 mg/g [288.2, 2917] postpartum, p = 0.09 vs. 81.5 mg/g [60.6, 105.5] three years later, p = 0.01. Two patients still had proteinuria after 3 years. Conclusions: in preeclampsia patients, postpartum urinary podocalyxin decreased before proteinuria. After three years, serum creatinine, urinary podocalyxin, and protein tended to normalize, although some patients still had proteinuria.
RESUMO Introdução: a pré-eclâmpsia pode estar associada à doença renal no futuro. Objetivos: medir mudanças na função renal ao longo do tempo em pacientes com pré-eclâmpsia. Métodos: amostras de urina e soro de onze pacientes com pré-eclâmpsia e oito pacientes com gravidez normal foram obtidas durante a gravidez, pós-parto e 3 anos após o parto. Medimos podocalixina na urina, proteína e creatinina sérica. Resultados: após 3 anos, não houve diferenças significativas na podocalixina urinária em pacientes com ou sem pré-eclâmpsia: 4,34 ng/mg [2,69, 8,99] versus 7,66 ng/mg [2,35, 13], p = 0,77. O mesmo se aplicou à excreção urinária de proteínas: 81,5 mg/g [60,6, 105,5] vs. 43,2 mg/g [20,9, 139,3] p = 0,23. A creatinina sérica foi de 0,86 mg/dL [0,7, 0,9] vs. 0,8 mg/dL [0,68, 1] p = 0,74 naqueles com e sem pré-eclâmpsia. Em pacientes normais, a podocalixina urinária diminuiu de 54,4 ng/mg [34,2, 76,9] durante a gestação para 7,66 ng/mg [2,35, 13] três anos após a gravidez, p = 0,01. A proteinúria diminuiu de 123,5 mg/g [65,9, 194,8] para 43,2 mg/g [20,9, 139,3], p = 0,12. Em pacientes com pré-eclâmpsia, a podocalixina urinária diminuiu de 97,5 ng/mg [64,9, 318,4] durante a gravidez para 37,1 ng/mg em uma semana de pós-parto [21,3, 100,4] p = 0,05 e 4,34 ng/mg [2,69, 8,99] três anos depois, p = 0,003. A proteinúria foi de 757,2 mg/g [268.4, 5031.7] durante a gravidez vs. 757,2 mg/g [288.2, 2917] pós-parto, p = 0.09 vs. 81.5 mg/g [60.6, 105.5] três anos depois, p = 0.01. Dois pacientes ainda apresentavam proteinúria após 3 anos. Conclusões: em pacientes com pré-eclâmpsia, a podocalixina urinária pós-parto diminuiu antes da proteinúria. Após três anos, a creatinina sérica, a podocalixina urinária e a proteína tenderam a se normalizar, embora alguns pacientes ainda tivessem proteinúria.
Asunto(s)
Humanos , Femenino , Adulto , Preeclampsia/fisiopatología , Podocitos/patología , Riñón/fisiopatología , Riñón/patología , Preeclampsia/orina , Preeclampsia/sangre , Sialoglicoproteínas/orina , Sialoglicoproteínas/sangre , Factores de Tiempo , Embarazo , Biomarcadores/orina , Biomarcadores/sangre , Estudios Prospectivos , Estudios de SeguimientoRESUMEN
INTRODUCTION: preeclampsia can be associated with future renal disease. OBJECTIVES: To measure changes in renal function overtime in patients with preeclampsia. METHODS: urine and serum samples from eleven patients with preeclampsia and eight patients with a normal pregnancy were obtained during pregnancy, postpartum, and 3 years after delivery. Urine podocalyxin, protein, and serum creatinine were measured. RESULTS: after 3 years, there were no significant differences in urinary podocalyxin in patients with or without preeclampsia: 4.34 ng/mg [2.69, 8.99] vs. 7.66 ng/mg [2.35, 13], p = 0.77. The same applied to urinary protein excretion: 81.5 mg/g [60.6, 105.5] vs. 43.2 mg/g [20.9, 139.3] p = 0.23. Serum creatinine was 0.86 mg/dL [0.7, 0.9] vs. 0.8 mg/dL [0.68, 1] p = 0.74 in those with and without preeclampsia. In normal patients, urinary podocalyxin decreased from 54.4 ng/mg [34.2, 76.9] during pregnancy to 7.66 ng/mg [2.35, 13] three years after pregnancy, p = 0.01. Proteinuria decreased from 123.5 mg/g [65.9, 194.8] to 43.2 mg/g [20.9, 139.3], p = 0.12. In preeclampsia patients, urinary podocalyxin decreased from 97.5 ng/mg [64.9, 318.4] during pregnancy to 37.1 ng/mg within one week post-partum [21.3, 100.4] p = 0.05 and 4.34 ng/mg [2.69, 8.99] three years after, p = 0.003. Proteinuria was 757.2 mg/g [268.4, 5031.7] during pregnancy vs. 757.2 mg/g [288.2, 2917] postpartum, p = 0.09 vs. 81.5 mg/g [60.6, 105.5] three years later, p = 0.01. Two patients still had proteinuria after 3 years. CONCLUSIONS: in preeclampsia patients, postpartum urinary podocalyxin decreased before proteinuria. After three years, serum creatinine, urinary podocalyxin, and protein tended to normalize, although some patients still had proteinuria.
Asunto(s)
Riñón/patología , Riñón/fisiopatología , Podocitos/patología , Preeclampsia/fisiopatología , Adulto , Biomarcadores/sangre , Biomarcadores/orina , Femenino , Estudios de Seguimiento , Humanos , Preeclampsia/sangre , Preeclampsia/orina , Embarazo , Estudios Prospectivos , Sialoglicoproteínas/sangre , Sialoglicoproteínas/orina , Factores de TiempoRESUMEN
Obesity is a widely recognized risk factor for several diseases, reaching an epidemic magnitude worldwide. Natural polyphenols may improve blood lipids and body weight, but their clinical relevance in the general population remains unclear. Thus, we aimed to analyze the relationship of intake of Ilex paraguariensis (I. paraguariensis) beverages to lipid profiles and body weight in a large patient population. Patients were recruited to participate in an educational program to change habits to a healthy lifestyle. Anamnesis, clinical and laboratory assessments were conducted at study enrollment and during followup. I. paraguariensis beverages were defined according to preparation as obtained by repeated cold water extraction (CWE), hot water infusions, or water and sugar decoction. Heavy drinkers were defined as those persons consuming >1 L/day of one or more preparation types. Participants (N = 18,287) aged ≥18 years entered the study. Overall prevalence of I. paraguariensis consumption was 91.2%. All three forms were drunk by 35.7%, whereas CWE + hot water infusion and CWE alone by 28.4% and 14.5% participants, respectively. Heavy CWE drinkers had lower total cholesterol (191.4 ± 49.4 vs. 194.6 ± 48.3 mg/dl, p = .02) and lower lowdensity lipoprotein cholesterol (118.6 ± 38.9 vs. 121.2 ± 47.1 mg/dl, p = .001), but body weight was higher (81.1 ± 16.8 vs. 77.2 ± 16.4 kg, p < .0001) compared with moderate drinkers. Fasting glucose was lower (104.5 ± 48.7 vs. 107.2 ± 49.5 mg/dl, p < .001), and consumption of carbohydrates was higher (36.3% vs. 28.7%, p < .001). A lowlipids highbodyweight paradox could be observed in a population of heavy drinkers of I. paraguariensis beverages. Induced hypoglycemia and compensatory higher intake of refined carbohydrates may represent a possible cause.
Asunto(s)
Bebidas/análisis , Peso Corporal , Ilex paraguariensis , Lípidos/sangre , Extractos Vegetales/farmacología , Adulto , Anciano , LDL-Colesterol/sangre , Femenino , Humanos , Masculino , Persona de Mediana Edad , Obesidad/tratamiento farmacológico , Polifenoles , Estudios ProspectivosRESUMEN
La evaluación formativa, viene a ser una nueva modalidad en el contexto educativo, su administración e implementación en los niveles de la educación superior por parte de los docentes ha sido restringido y a veces desautorizado, dado el imperceptible nivel de información que ha tenido esta modalidad de evaluación, tal y como lo demuestran investigaciones previas a este trabajo. La oferta de cursos y talleres sobre la administración de la evaluación formativa y su instrumentación en el aula de clase ha sido prácticamente inexistente. Este trabajo ha sido diseñado con la intención de hacer algúnos aportes a su conocimiento, divulgar las bondades de esta modalidad y, al mismo tiempo sugerir algúnas estratégias para su operatividad en el aula. Es así como se propone un modelo operativo para obtener un provecho significativo de su administración teniendo como propósito primordial un incremento sostenido del rendimiento académico de nuestros estudiantes.
Asunto(s)
Universidades , AprendizajeRESUMEN
La evaluación formativa, viene a ser una nueva modalidad en el contexto educativo, su administración e implementación en los niveles de la educación superior por parte de los docentes ha sido restringido y a veces desautorizado, dado el imperceptible nivel de información que ha tenido esta modalidad de evaluación, tal y como lo demuestran investigaciones previas a este trabajo. La oferta de cursos y talleres sobre la administración de la evaluación formativa y su instrumentación en el aula de clase ha sido prácticamente inexistente. Este trabajo ha sido diseñado con la intención de hacer algúnos aportes a su conocimiento, divulgar las bondades de esta modalidad y, al mismo tiempo sugerir algúnas estratégias para su operatividad en el aula. Es así como se propone un modelo operativo para obtener un provecho significativo de su administración teniendo como propósito primordial un incremento sostenido del rendimiento académico de nuestros estudiantes.
Asunto(s)
Universidades , AprendizajeRESUMEN
Los autores procesan mediante cromatografia "batch" 169 muestras de sangre de animales (caninos, bovinos, equinos, felinos, gallinas) y seres humanos con el objeto de obtener valores de referencia para hemoglobina glicosilada (glucoHb) en el nordeste argentino. Este parámetro bioquímico tiene interés en diabetología al brindar información sobre la glucemia de los últimos 60 días y permitiría un mejor control de la terapia insulínica en medicina veterinaria. La técnica programada para el ser humano, arrojó valores discordantes en herbívoros, aunque en caninos, felinos y gallinas resultó aplicable prima-facie, obteniéndose niveles promedios de 10.81, 8.32 y 9.02 por ciento respectivamente. Las muestrass humanas utilizadas como control mostraron tasas de 7.34 + ou - 1.13 por ciento en individuos sanos. Se discuten las variaciones fisiológicas observadas (sexo, edad, temperatura ambiente, estado del plasma) y se reportan datos de glucoHb y glicemia en pacientes diabéticos tratados y no tratados